Trevena
TRVN
#11371
Rank
โ‚ฌ0 M
Marketcap
0,0004556ย โ‚ฌ
Share price
0.00%
Change (1 day)
-94.74%
Change (1 year)

Earnings for Trevena (TRVN)

Earnings in 2024 (TTM): -โ‚ฌ28.34 Million

According to Trevena's latest financial reports the company's current earnings are โ‚ฌ0.54 Million. In 2023 the company made an earning of -โ‚ฌ33.11 Million, an increase over its 2022 earnings that were of -โ‚ฌ47.76 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevena from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ28.34 Million-14.4%
2023 -โ‚ฌ33.11 Million-30.69%
2022 -โ‚ฌ47.76 Million1.38%
2021 -โ‚ฌ47.12 Million78.04%
2020 -โ‚ฌ26.47 Million21.3%
2019 -โ‚ฌ21.82 Million-13.91%
2018 -โ‚ฌ25.34 Million-59.75%
2017 -โ‚ฌ62.96 Million-31.77%
2016 -โ‚ฌ92.27 Million101.73%
2015 -โ‚ฌ45.74 Million1.14%
2014 -โ‚ฌ45.23 Million114.83%
2013 -โ‚ฌ21.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚ฌ10.07 B-35,687.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ6.12 B-21,747.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-โ‚ฌ72.34 Million 155.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-โ‚ฌ0.71 Billion 2,404.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-โ‚ฌ9.38 Million-66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-โ‚ฌ57.22 Million 102.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-โ‚ฌ0.58 Billion 1,918.69%๐Ÿ‡บ๐Ÿ‡ธ USA